These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10918521)

  • 21. Improved detection of transgene and nonviral vectors in blood.
    Baoutina A; Coldham T; Fuller B; Emslie KR
    Hum Gene Ther Methods; 2013 Dec; 24(6):345-54. PubMed ID: 23971678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Application of PCR technology in vaccine product development.
    Wolf JJ; Wang L; Wang F
    Expert Rev Vaccines; 2007 Aug; 6(4):547-58. PubMed ID: 17669009
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assuring the quality, safety, and efficacy of DNA vaccines.
    Robertson JS; Griffiths E
    Mol Biotechnol; 2001 Feb; 17(2):143-9. PubMed ID: 11395863
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Marker-free plasmids for biotechnological applications - implications and perspectives.
    Oliveira PH; Mairhofer J
    Trends Biotechnol; 2013 Sep; 31(9):539-47. PubMed ID: 23830144
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The mechanism of naked DNA uptake and expression.
    Wolff JA; Budker V
    Adv Genet; 2005; 54():3-20. PubMed ID: 16096005
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monitoring for potential adverse effects of prenatal gene therapy: genotoxicity analysis in vitro and on small animal models ex vivo and in vivo.
    Themis M
    Methods Mol Biol; 2012; 891():341-70. PubMed ID: 22648780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulatory acceptance of animal models of disease to support clinical trials of medicines and advanced therapy medicinal products.
    Cavagnaro J; Silva Lima B
    Eur J Pharmacol; 2015 Jul; 759():51-62. PubMed ID: 25814257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vector PCR.
    Runnebaum IB; Syka P; Sukumar S
    Biotechniques; 1991 Oct; 11(4):446-8, 450-2. PubMed ID: 1793574
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The assessment of local tolerance, acute toxicity, and DNA biodistribution following particle-mediated delivery of a DNA vaccine to minipigs.
    Pilling AM; Harman RM; Jones SA; McCormack NA; Lavender D; Haworth R
    Toxicol Pathol; 2002; 30(3):298-305. PubMed ID: 12051546
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Positive selection vectors for high-fidelity PCR cloning.
    Malo MS; Husain Z
    Biotechniques; 2003 Jun; 34(6):1250-8. PubMed ID: 12813893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. II. Cationic lipid-formulated plasmid DNA-based Bacillus anthracis vaccine: evaluation of plasmid DNA persistence and integration potential.
    Vilalta A; Mahajan RK; Hartikka J; Leamy V; Martin T; Rusalov D; Bozoukova V; Lalor P; Hall K; Kaslow DC; Rolland A
    Hum Gene Ther; 2005 Oct; 16(10):1151-6. PubMed ID: 16218776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of gene therapy for treatment of age-related macular degeneration.
    Askou AL
    Acta Ophthalmol; 2014 Jul; 92 Thesis3():1-38. PubMed ID: 24953666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of nonviral gene transfer in the canine brain.
    Oh S; Pluhar GE; McNeil EA; Kroeger KM; Liu C; Castro MG; Lowenstein PR; Freese A; Ohlfest JR
    J Neurosurg; 2007 Jul; 107(1):136-44. PubMed ID: 17639883
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monitoring veterinary vaccines for contaminating viruses.
    Ottiger HP
    Dev Biol (Basel); 2006; 126():309-19; discussion 327. PubMed ID: 17058507
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overview of global regulatory toxicology requirements for vaccines and adjuvants.
    Sun Y; Gruber M; Matsumoto M
    J Pharmacol Toxicol Methods; 2012 Mar; 65(2):49-57. PubMed ID: 22326278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA vaccines.
    Donnelly JJ; Ulmer JB; Shiver JW; Liu MA
    Annu Rev Immunol; 1997; 15():617-48. PubMed ID: 9143702
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RNA-based vaccines.
    Ulmer JB; Mason PW; Geall A; Mandl CW
    Vaccine; 2012 Jun; 30(30):4414-8. PubMed ID: 22546329
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection and direct genomic sequencing of multiple rare unknown flanking DNA in highly complex samples.
    Schmidt M; Hoffmann G; Wissler M; Lemke N; Müssig A; Glimm H; Williams DA; Ragg S; Hesemann CU; von Kalle C
    Hum Gene Ther; 2001 May; 12(7):743-9. PubMed ID: 11339891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sensitivity by combination: immuno-PCR and related technologies.
    Adler M; Wacker R; Niemeyer CM
    Analyst; 2008 Jun; 133(6):702-18. PubMed ID: 18493669
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biosafety of DNA vaccines: New generation of DNA vectors and current knowledge on the fate of plasmids after injection.
    Faurez F; Dory D; Le Moigne V; Gravier R; Jestin A
    Vaccine; 2010 May; 28(23):3888-95. PubMed ID: 20371391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.